Search Results 941-950 of 18555 for hepatitis

  1. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    - Have active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. - Has an active autoimmune disease that has required systemic treatment in the ...

  2. Golimumab (intravenous route, subcutaneous route) - Mayo Clinic

    Hepatitis B, history of or; Immune system problem or; Primary sclerosing cholangitis (bile duct disease) or; Tuberculosis, history of or; Granulomatosis ...

  3. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

    Subjects with concomitant liver diseases including chronic viral hepatitis B or C, autoimmune hepatitis, PSC, alcoholic liver disease, Wilson's disease, ...

  4. A Study to Evaluate Smartphone-based Digital Phenotyping for Relapse Prediction in Alcohol-associated Liver Disease - Mayo Clinic

    ... hepatitis, compatible clinical, imaging, and laboratory findings and typical histology on liver biopsy, if performed;; The diagnosis of AUD will be ...

  5. Upadacitinib (oral route) - Side effects & dosage - Mayo Clinic

    May make these conditions worse. Heart or blood vessel disease or; Hepatitis B, history of or; Hepatitis C, history of or; Herpes zoster infection or ...

  6. Treating Acute Pancreatitis with Dabigatran - Mayo Clinic

    Active hepatitis C, active hepatitis B, and active hepatitis A. Anemia (hemoglobin < 10 g/dL). Thrombocytopenia (platelet count < 100 x 10^9/L. Concomitant ...

  7. Publications - James W. Williams, M.D. - Mayo Clinic

    Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver ...

  8. A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet - Mayo Clinic

    ... hepatitis B virus surface antigen and quantitative hepatitis B virus polymerase chain reaction (PCR), or positive serology for hepatitis C virus (HCV) and ...

  9. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

    Evidence of hepatitis B Virus (HBV) or hepatitis C Virus (HCV) infection. NOTE: Patients with laboratory evidence of cleared HBV or HCV infection may ...

  10. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Patients that are positive for hepatitis B core antibody, hepatitis B surface antigen (HBsAg), or hepatitis C antibody must have a negative polymerase chain ...